Literature DB >> 11502320

Frequency of C3435T polymorphism of MDR1 gene in African people.

E Schaeffeler, M Eichelbaum, U Brinkmann, A Penger, S Asante-Poku, U M Zanger, M Schwab.   

Abstract

The variability of P-glycoprotein expression between individuals is linked to a C3435T polymorphism of the human MDR1 gene. Concentration of P-glycoprotein in intestinal epithelial cells and in a subset of lymphoid cells is substantially lower in people with the T/T genotype than those with the C/C genotype. We compared allele frequencies of the C3435T polymorphism in random samples of west African, African American, white, and Japanese people. We recorded a significantly higher frequency of the C/C genotype in West Africans and African Americans (142 of 172 [83%] and 25 of 41 [61%], respectively), than in white people (139 of 537 [26%]) (p<0.0001). These findings could affect use of drugs that are P-glycoprotein substrates (such as HIV-1 protease inhibitors and ciclosporin) in African populations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502320     DOI: 10.1016/S0140-6736(01)05579-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  50 in total

1.  Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population.

Authors:  Samar I Hamdy; Masahiro Hiratsuka; Kaori Narahara; Naomi Endo; Mervat El-Enany; Nadia Moursi; Mohammed S-E Ahmed; Michinao Mizugaki
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

2.  Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates.

Authors:  C Balram; A Sharma; C Sivathasan; Edmund J D Lee
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

3.  Detection of MDR1 single nucleotide polymorphisms C3435T and G2677T using real-time polymerase chain reaction: MDR1 single nucleotide polymorphism genotyping assay.

Authors:  Pengfei Song; Shen Li; Bernd Meibohm; A Osama Gaber; Marsha R Honaker; Malak Kotb; Charles R Yates
Journal:  AAPS PharmSci       Date:  2002

Review 4.  P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

Authors:  Sanjay U C Sankatsing; Jos H Beijnen; Alfred H Schinkel; Joep M A Lange; Jan M Prins
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

Review 5.  Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents.

Authors:  Margalida Rotger; Chantal Csajka; Amalio Telenti
Journal:  Curr HIV/AIDS Rep       Date:  2006-09       Impact factor: 5.071

6.  Study of ABCB1 polymorphism (C3435T) in HIV-1-infected individuals from South India.

Authors:  Siddharth Bakshi; Geetha Ramachandran; Karunaianandham Ramesh; Agibothu K Hemanthkumar; Suresh Anitha; Chandrasekaran Padmapriyadarsini; Gopalan Narendran; Pradeep A Menon; Sikhamani Rajasekaran; Soumya Swaminathan
Journal:  Br J Clin Pharmacol       Date:  2008-01-30       Impact factor: 4.335

7.  Polymorphism C3435T of the MDR1 gene in Central Americans and Spaniards.

Authors:  J Vicente; Blanca Sinues; A Fanlo; P Vasquez; J C Medina; B Martinez-Jarreta
Journal:  Mol Biol Rep       Date:  2007-06-19       Impact factor: 2.316

8.  Common single nucleotide polymorphisms of the MDR1 gene have no influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients.

Authors:  Yuichi Uwai; Satohiro Masuda; Maki Goto; Hideyuki Motohashi; Hideyuki Saito; Masahiro Okuda; Eijirou Nakamura; Noriyuki Ito; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Hum Genet       Date:  2003-12-18       Impact factor: 3.172

9.  Role of multidrug transporters in neurotherapeutics.

Authors:  Manna Jose; Sanjeev V Thomas
Journal:  Ann Indian Acad Neurol       Date:  2009-04       Impact factor: 1.383

10.  Novel insertion mutation of ABCB1 gene in an ivermectin-sensitive Border Collie.

Authors:  Jae-Ik Han; Hyoung-Won Son; Seung-Cheol Park; Ki-Jeong Na
Journal:  J Vet Sci       Date:  2010-12       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.